Walmart plans to provide specific medications without charge for individuals diagnosed with Type 2 diabetes. The company will offer Ozempic from Novo and Mounjaro from Lilly, ensuring these treatments are accessible at no personal cost. This initiative aims to help patients requiring these particular drugs.
Access to these medications will be contingent on a new prior authorization process. This condition ensures that the treatments are approved through a specific protocol before being dispensed free of charge. Walmart's decision directly addresses the availability of these two key brand name drugs for the Type 2 diabetes community.